Ten year hormonal therapy cuts breast cancer relapse
Study suggests recurrence risk is cut by a thirdRelated items from OnMedicaHigh insulin levels linked to worse prognosis in advanced breast cancerHigh white blood cell ratio linked to recurrent cancerPartial radiotherapy suitable for early breast cancerRadiotherapy during breast cancer surgery cuts cost and time (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 6, 2016 Category: UK Health Source Type: news

Cancer treatment good but aftercare less so
Scotland publishes cancer patient surveyRelated items from OnMedicaTen year hormonal therapy cuts breast cancer relapse Lung cancer surgery survival increasesEU membership best for cancer patients and research, say leading oncologistsEnd-of-life care heading for ‘meltdown’ without cash boost, warns cancer charity chiefNHS England promises world-class cancer services (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 6, 2016 Category: UK Health Source Type: news

Extending anti-estrogen therapy to 10 years reduces breast-cancer recurrence, new cancers
CHICAGO — Researchers said extending anti-estrogen hormone therapy to 10 years reduces the risk of a recurrence of breast cancer in many older women and decreases the chance of a new cancer emerging in the other, healthy breast. The study, which was released Sunday at the annual meeting of the American Society of Clinical Oncology, […] (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 5, 2016 Category: Consumer Health News Authors: Laurie McGinley Tags: biomedical research cancer Source Type: news

Could statins prevent breast cancer returning?
Conclusion The study aimed to identify biological pathways that could be the reason why some ER+ breast cancers relapse after oestrogen-blocking treatment. It seems that one of the answers for treatment resistance lies in increased activity of cholesterol-producing pathways in the absence of oestrogen. The cholesterol molecules mimic oestrogen and stimulate further tumour growth. The researchers hope that their research could potentially highlight a new pathway, which could be used as a target for therapeutic treatment in the future. Dr Lesley-Ann Martin from the research team told the media, "This is hugely significa...
Source: NHS News Feed - June 2, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Estrogen Benefits Bones in Transgender Hormone ConversionEstrogen Benefits Bones in Transgender Hormone Conversion
One year of transgender hormone therapy shows the greatest increase in bone-mineral density in male-to-female conversions, while female-to-male conversions benefit most in postmenopausal women. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 1, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

GMC stands by guidance urging GPs to prescribe hormones to trans patients
The GMC has defended its advice that GPs should prescribe hormone therapy to transgender patients in some cases, despite GPC concerns that it would push them to prescribe beyond their competence. (Source: GP Online News)
Source: GP Online News - May 31, 2016 Category: Primary Care Tags: Endocrine Source Type: news

The risks of active surveillance for men with intermediate-risk prostate cancers
Men diagnosed with slow-growing prostate tumors that likely won’t be harmful during their lifetimes can often avoid immediate treatment. Instead, they can have their tumor monitored using a strategy called active surveillance. With this approach, doctors perform periodic checks for tumor progression and start treatment only if the cancer begins to metastasize, or spread. Active surveillance has become popular worldwide, but doctors still debate which groups of men can safely use this strategy. Some doctors offer it only to men with the lowest risk of cancer progression. Others say that men with intermediate-risk pros...
Source: New Harvard Health Information - May 27, 2016 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Men's Health Prostate Health Source Type: news

Scientists Block Breast Cancer Cells From Hiding in Bones
Contact: Samiha Khanna Phone: 919-419-5069 Email: samiha.khanna@duke.edu https://www.dukehealth.org EMBARGOED FOR RELEASE until 2 p.m. (ET) on WEDNESDAY, MAY 25, 2016 Scientists Block Breast Cancer Cells From Hiding in Bones DURHAM, N.C. -- Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.  Through years of experiments in mice, the scientists have found ways to outmaneuver this stealth tactic by not only preventing breast cancer cells...
Source: DukeHealth.org: Duke Health Features - May 26, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

GMC transgender advice could push GPs to prescribe beyond competence, warns GPC
GMC guidance that calls for GPs to initiate hormone therapy in some transgender patients before they see a specialist could make GPs 'feel coerced' into prescribing specialist drugs outside of their clinical competence, the GPC has warned. (Source: GP Online News)
Source: GP Online News - May 17, 2016 Category: Primary Care Tags: Clinical News Source Type: news

Radiotherapy halves deaths from prostate cancer 15 years after diagnosis
A study published in the journal European Urology shows that a combination of hormone therapy with local radiotherapy halves the risk of death from prostate cancer 15 years after diagnosis. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 10, 2016 Category: Endocrinology Source Type: news

Prostate cancer drugs DOUBLE the risk of Alzheimer's... which sells even more drugs for Big Pharma
(NaturalNews) Prostate cancer patients who receive hormone therapy as part of their treatment are twice as likely to develop Alzheimer's and face an increased risk of depression, a pair of recent studies has shown.A common treatment for prostate cancer involves the use of androgen... (Source: NaturalNews.com)
Source: NaturalNews.com - May 4, 2016 Category: Consumer Health News Source Type: news

Compounded Non-FDA-approved Menopausal Hormone TherapyCompounded Non-FDA-approved Menopausal Hormone Therapy
What is compounded hormone therapy, are there specific risks with it, and how often is it being prescribed for menopausal women? Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Is Pre- or Postmenopausal Hormonal Therapy OK After VTE? Is Pre- or Postmenopausal Hormonal Therapy OK After VTE?
Dr Goldhaber comments on an analysis of the EINSTEIN study suggesting that women with a history of DVT can take postmenopausal hormone therapy or oral contraceptives. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 28, 2016 Category: Cardiology Tags: Cardiology Commentary Source Type: news

No increased risk of fatal cardiovascular events for breast cancer patients on newer hormone therapy
The use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular events, including heart attacks or stroke, compared with tamoxifen, another commonly prescribed anti-cancer drug that works on hormones and which has been associated with a serious risk of stroke, report investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 21, 2016 Category: Science Source Type: news

Is Hormone Therapy Safe After Ovarian Cancer?
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 21, 2016 Category: Journals (General) Source Type: news

No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
(Kaiser Permanente) In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular events, including heart attacks or stroke, compared with tamoxifen, another commonly prescribed anti-cancer drug that works on hormones and which has been associated with a serious risk of stroke. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 21, 2016 Category: Cancer & Oncology Source Type: news

Review Calls for More Research on Transgender Hormone Therapy Review Calls for More Research on Transgender Hormone Therapy
A new review details the benefits, risks, and effects of testosterone therapy in transgender men, highlighting the lack of long-term data and calling for more research that can help guide patient care. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 20, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hormone Therapy Safe After Ovarian CancerHormone Therapy Safe After Ovarian Cancer
Hormone therapy use after treatment for nonserous epithelial ovarian cancer was not tied to reduced overall survival, and may have extended disease-free survival in women younger than 55 years. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Use of Compounded Hormone Therapy in the United StatesUse of Compounded Hormone Therapy in the United States
How many menopausal and postmenopausal women in the US are taking compounded hormone therapy, and how safe and effective is it? Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Medical News Today: Prostate cancer hormone therapy may increase risk of depression
Men receiving androgen deprivation therapy for localized prostate cancer have a significantly higher risk of developing depression, according to a new study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2016 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Prostate cancer hormone therapy tied to higher depression risk
(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of depression than patients who receive different treatment for these malignancies, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Can you stop a paedophile before they've abused a child?
A clinical trial is seeking crowd-funding to test hormone therapy drugs on paedophile volunteers to test whether it might help prevent abuse in the first place. BBC News (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 12, 2016 Category: Endocrinology Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
Title: Hormone Therapy for Prostate Cancer Tied to DepressionCategory: Health NewsCreated: 4/11/2016 12:00:00 AMLast Editorial Review: 4/12/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 12, 2016 Category: Cancer & Oncology Source Type: news

Hormone Therapy for Prostate Cancer May Increase Risk of Depression
Study suggests androgen deprivation therapy for localized prostate cancer may increase the risk of depression (Source: BWH for Journalists)
Source: BWH for Journalists - April 12, 2016 Category: Research Source Type: news

Hormone Therapy for Prostate Cancer May Increase Risk of Depression
Study suggests androgen deprivation therapy for localized prostate cancer may increase the risk of depression (Source: BWH News)
Source: BWH News - April 12, 2016 Category: Hospital Management Source Type: news

Hormone therapy for prostate cancer tied to depression
Amy Norton, HealthDay News Older men who receive testosterone-suppressing therapy for prostate cancer may be at increased risk of developing depression, a new, large study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 12, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy for Prostate Cancer Tied to This
Study found a 23 percent increased risk compared to men who received other treatments, but overall risk relatively low (Source: WebMD Health)
Source: WebMD Health - April 12, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
Study found a 23 percent increased risk compared to men who received other treatments, but overall risk relatively low (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 11, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Endocrinology, Nursing, Oncology, Psychiatry, Reproductive Medicine, News, Source Type: news

Well: Hormone Therapy for Prostate Cancer Tied to Depression
Androgen deprivation therapy, a widely used prostate cancer treatment, may increase depression risk. (Source: NYT)
Source: NYT - April 11, 2016 Category: American Health Authors: NICHOLAS BAKALAR Tags: Mental Health and Disorders Hormones Mind Featured Testosterone Source Type: news

Well: Hormone Therapy for Prostate Cancer Tied to Depression
Androgen deprivation therapy, a widely used prostate cancer treatment, may increase depression risk. (Source: NYT Health)
Source: NYT Health - April 11, 2016 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Mental Health and Disorders Hormones Mind Featured Testosterone Source Type: news

Well: Hormone Therapy for Prostate Cancer Tied to Depression
Androgen deprivation therapy, a widely used prostate cancer treatment, may increase depression risk. (Source: NYT)
Source: NYT - April 11, 2016 Category: Nutrition Authors: NICHOLAS BAKALAR Tags: Mental Health and Disorders Hormones Mind Featured Testosterone Source Type: news

Well: Hormone Therapy for Prostate Cancer Tied to Depression
Androgen deprivation therapy, a widely used prostate cancer treatment, may increase depression risk. (Source: NYT Health)
Source: NYT Health - April 11, 2016 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Hormones Mental Health and Disorders Testosterone Featured Mind Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
Study found a 23 percent increased risk compared to men who received other treatments, but overall risk relatively low (Source: U.S. News - Health)
Source: U.S. News - Health - April 11, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
Study found a 23 percent increased risk compared to men who received other treatments, but overall risk relatively low Source: HealthDay Related MedlinePlus Pages: Depression, Prostate Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 11, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
MONDAY, April 11, 2016 -- Older men who receive testosterone-suppressing therapy for prostate cancer may be at increased risk of developing depression, a new, large study suggests. The findings are based on over 78,000 U.S. men treated for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2016 Category: Journals (General) Source Type: news

Scientists seek crowdfunding for paedophilia drug trial
Swedish researchers are using a British funding platform to finance trials of a controversial drug therapy, which they hope will reduce child sexual abuseSwedish scientists want research funds to test what they see as preventive treatment for potential paedophiles. They plan to use a British crowdfunding website to finance full-scale scientific trials of a drug treatment that could, they hope, reduce the likelihood of child sexual abuse.The volunteers in the trial would be 60 Swedish men who have sought help; half would receive injections of a placebo. The other 30 would be treated with a hormone therapy called degarelix, ...
Source: Guardian Unlimited Science - April 7, 2016 Category: Science Authors: Tim Radford Tags: Child protection Research funding Medical research Mental health Society Science Crowdfunding Sweden Ethics Psychology Source Type: news

ELITE Provides Reassurance About Estrogen in Early MenopauseELITE Provides Reassurance About Estrogen in Early Menopause
The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 6, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Is testosterone the key to weight loss?
Scientists from University of Melbourne gave 49 dieting obese men testosterone injections, and 51 placebo, and found those taking hormone therapy lost more weight overall - but not muscle. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2016 Category: Consumer Health News Source Type: news

Can HRT in early menopause cut heart disease risk?
ConclusionThis double-blind RCT found that women taking HRT less than six years after the menopause had slower artery wall thickening than those taking a placebo. This represented the main measure of atherosclerosis progression tested; other measures showed no difference, so the results were not as conclusive as they could have been. Women taking HRT 10 or more years after menopause also showed no difference in atherosclerosis progression compared with a placebo, further complicating the picture.An important limitation of this study is the lack of a patient relevant endpoint, such as cardiovascular events or mortality. Pre...
Source: NHS News Feed - April 1, 2016 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Swedish population study helps answer lingering questions about hormone therapy safety
Oestrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the oestrogen is transdermal, according a Swedish study investigating the safety of HRT in Menopause. News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 31, 2016 Category: Endocrinology Source Type: news

HRT Slows Atherosclerosis Progression in Early Menopause (CME/CE)
(MedPage Today) -- But hormonal therapy expressly for cardiac benefit still not recommended (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 31, 2016 Category: Cardiology Source Type: news

Does Hormone Therapy Slow Atherosclerosis Progression? It's All About the Timing (FREE)
By Andrew M. Kaunitz, MD, and JoAnn Manson, MD, DrPH Dr. Kaunitz is the editor-in-chief and Dr. Manson is a guest editor for NEJM Journal Watch Women's Health, from which this story was adapted. Full coverage is available at the link below.Hormone therapy (HT) slows atherosclerosis progression in recently menopausal women but not … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 31, 2016 Category: Primary Care Source Type: news

Possible Heart Benefits Of Taking Estrogen Get Another Look
Evidence has ping-ponged over the decades on the effects of hormone therapy on a woman's arteries. The latest study suggests a brief stint on hormones might be helpful — if given at the right time. (Source: NPR Health and Science)
Source: NPR Health and Science - March 30, 2016 Category: Consumer Health News Authors: Rae Ellen Bichell Source Type: news

Only ‘early’ estradiol limits atherosclerosis progression
Hormone therapy – estradiol with or without progesterone – only limits the progression of subclinical atherosclerosis if it is initiated within 6 years of menopause onset, according to a report... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 30, 2016 Category: Endocrinology Source Type: news

Blood clot risk lower for estrogen-only, transdermal, and vaginal estrogen at menopause
A Swedish population study is helping answer lingering questions about hormone therapy safety. The study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 30, 2016 Category: Science Source Type: news

Blood clot risk lower for estrogen-only, transdermal, and vaginal estrogen at menopause
(The North American Menopause Society (NAMS)) A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of the North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2016 Category: Global & Universal Source Type: news

8 Things Every Woman Should Know About Her Libido
By Hallie Levine Here today, gone tomorrow--your libido can be puzzling, to say the least. But that ebb and flow is completely natural, says Lauren Streicher, MD, clinical associate professor of obstetrics and gynecology at Northwestern Memorial Hospital in Chicago: "All women go through periods when they feel especially frisky, as well as times when they just seem to have lost their mojo." Read on to learn about the many reasons your libido may come and go, and how to find it when you miss it. Curious about aphrodisiacs? We've got those too, from strawberries to Savasana. RELATED: 9 Things Every Woman Must Know ...
Source: Healthy Living - The Huffington Post - March 29, 2016 Category: Consumer Health News Source Type: news

GPs could initiate hormone therapy for transgender patients, says GMC
GPs should consider prescribing 'bridging' hormone treatment to transgender patients attempting to self-medicate while they await specialised gender identity treatment, GMC guidance recommends. (Source: GP Online News)
Source: GP Online News - March 21, 2016 Category: Primary Care Tags: Clinical News Source Type: news